FDA Approved: TERBUTALINE SULFATE — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

FDA approved a supplemental application for Terbutaline Sulfate filed by Chartwell RX, LLC., indicating approval of this generic product under ANDA 077152.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Preterm Labor

Drugs mentioned

• Terbutaline sulfate (terbutaline sulfate)

Snippet

SUPPL AP for TERBUTALINE SULFATE (TERBUTALINE SULFATE)